دورية أكاديمية
Function and Mechanism of RGD in Bone and Cartilage Tissue Engineering.
| العنوان: | Function and Mechanism of RGD in Bone and Cartilage Tissue Engineering. |
|---|---|
| المؤلفون: | Yang M; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China.; School of Clinical Medicine, Weifang Medical University, Weifang, China., Zhang ZC; Beijing National Laboratory for Molecular Sciences, Center for Soft Matter Science and Engineering, Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, China., Liu Y; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China., Chen YR; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China., Deng RH; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China., Zhang ZN; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China., Yu JK; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China.; School of Clinical Medicine, Weifang Medical University, Weifang, China., Yuan FZ; Sports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.; Institute of Sports Medicine of Peking University, Beijing, China. |
| المصدر: | Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Dec 15; Vol. 9, pp. 773636. Date of Electronic Publication: 2021 Dec 15 (Print Publication: 2021). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Media S.A., [2013]- |
| مستخلص: | Bone and cartilage injury is common, tissue engineered scaffolds are potential means to repair. Because most of the scaffold materials used in bone and cartilage tissue engineering are bio-inert, it is necessary to increase the cellular adhesion ability of during tissue engineering reconstruction. The Arginine - Glycine - Aspartic acid (Arg-Gly-Asp, RGD) peptide family is considered as a specific recognition site for the integrin receptors. Integrin receptors are key regulators of cell-cell and cell-extracellular microenvironment communication. Therefore, the RGD polypeptide families are considered as suitable candidates for treatment of a variety of diseases and for the regeneration of various tissues and organs. Many scaffold material for tissue engineering and has been approved by US Food and Drug Administration (FDA) for human using. The application of RGD peptides in bone and cartilage tissue engineering was reported seldom. Only a few reviews have summarized the applications of RGD peptide with alloy, bone cements, and PCL in bone tissue engineering. Herein, we summarize the application progress of RGD in bone and cartilage tissue engineering, discuss the effects of structure, sequence, concentration, mechanical stimulation, physicochemical stimulation, and time stimulation of RGD peptide on cells differentiation, and introduce the mechanism of RGD peptide through integrin in the field of bone and cartilage tissue engineering. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Yang, Zhang, Liu, Chen, Deng, Zhang, Yu and Yuan.) |
| References: | ACS Appl Mater Interfaces. 2016 Jun 8;8(22):13812-8. (PMID: 27182777) Molecules. 2010 Jan 06;15(1):178-97. (PMID: 20110882) Biomaterials. 2019 Apr;200:15-24. (PMID: 30743050) Biomaterials. 2002 Nov;23(22):4315-23. (PMID: 12219821) J Dent Res. 2001 Jun;80(6):1540-4. (PMID: 11499509) Ann Rheum Dis. 1998 May;57(5):303-8. (PMID: 9741315) Annu Rev Cell Dev Biol. 1996;12:697-715. (PMID: 8970741) Cell Tissue Res. 2010 Jan;339(1):121-30. (PMID: 19588168) Dent Mater. 2019 Jul;35(7):1031-1041. (PMID: 31076156) Bioeng Transl Med. 2020 Dec 15;6(2):e10206. (PMID: 34027093) J Pept Res. 1999 May;53(5):530-41. (PMID: 10424348) J Mater Chem B. 2020 Sep 23;8(36):8149-8170. (PMID: 32776030) Biomaterials. 2014 Aug;35(25):6871-81. (PMID: 24840616) Acta Biomater. 2013 Apr;9(4):6095-104. (PMID: 23291491) Am J Gastroenterol. 2021 Feb 1;116(2):319-328. (PMID: 33165006) Osteoarthritis Cartilage. 2006 Jan;14(1):13-29. (PMID: 16242352) Genome Biol. 2007;8(5):215. (PMID: 17543136) Tissue Eng Part A. 2009 Jun;15(6):1201-9. (PMID: 18991487) Macromol Rapid Commun. 2010 Jul 1;31(13):1148-54. (PMID: 21590868) Nano Lett. 2015 Jul 8;15(7):4720-9. (PMID: 26027605) J Immunol. 2000 Mar 1;164(5):2684-91. (PMID: 10679109) Lancet. 2018 May 19;391(10134):1985. (PMID: 29864015) Clin Oral Implants Res. 2011 Aug;22(8):865-72. (PMID: 21244501) Clin Oral Investig. 2000 Jun;4(2):126-9. (PMID: 11218500) Biomaterials. 2005 Sep;26(25):5209-20. (PMID: 15792548) Acta Biomater. 2021 Feb;121:180-192. (PMID: 33249226) J Med Chem. 2001 Jun 7;44(12):1938-50. (PMID: 11384239) Pharm Res. 2008 Oct;25(10):2357-69. (PMID: 18509601) J Biomed Mater Res A. 2013 Oct;101(10):2905-14. (PMID: 23529934) Biomed Mater. 2018 May 02;13(4):045009. (PMID: 29611815) Adv Healthc Mater. 2016 May;5(10):1192-202. (PMID: 26959641) Curr Med Chem. 2005;12(1):51-70. (PMID: 15638730) Eur Cell Mater. 2010 Nov 11;20:316-28. (PMID: 21069635) Nat Commun. 2021 Apr 12;12(1):2174. (PMID: 33846342) Biomaterials. 2011 Nov;32(32):8048-57. (PMID: 21810538) Acta Biomater. 2009 Oct;5(8):2832-46. (PMID: 19508905) ACS Appl Mater Interfaces. 2016 Aug 31;8(34):21903-13. (PMID: 26600563) Cell Tissue Res. 2010 Jan;339(1):269-80. (PMID: 19693543) Adv Healthc Mater. 2017 Nov;6(22):. (PMID: 28804984) Acta Biomater. 2011 Nov;7(11):3829-40. (PMID: 21742067) Acta Biomater. 2021 Mar 15;123:31-50. (PMID: 33444800) Matrix Biol. 2005 May;24(3):208-18. (PMID: 15896949) J Tissue Eng Regen Med. 2019 Aug;13(8):1275-1293. (PMID: 30946537) Matrix Biol. 2014 Oct;39:11-6. (PMID: 25169886) J Biomed Mater Res A. 2018 Jan;106(1):33-42. (PMID: 28875574) J Biomed Mater Res A. 2020 Apr;108(4):839-850. (PMID: 31854488) J Biotechnol. 2005 Mar 2;116(1):51-9. (PMID: 15652429) Biotechnol J. 2015 Oct;10(10):1568-77. (PMID: 25641582) Biomaterials. 2017 Sep;139:127-138. (PMID: 28601703) Acta Biomater. 2013 Jul;9(7):7420-8. (PMID: 23567942) J Cell Sci. 1996 Jun;109 ( Pt 6):1369-80. (PMID: 8799825) Biomaterials. 2009 Feb;30(6):1089-97. (PMID: 19027948) Biomaterials. 2002 Jan;23(2):585-96. (PMID: 11761179) J Tissue Eng. 2020 Jun 2;11:2041731420926840. (PMID: 32537121) Pharm Res. 2008 Oct;25(10):2379-86. (PMID: 18509600) Trends Cancer. 2018 Aug;4(8):537-552. (PMID: 30064662) Int J Biochem Cell Biol. 1997 May;29(5):721-5. (PMID: 9251239) Tissue Eng Part A. 2013 Sep;19(17-18):2014-23. (PMID: 23627869) Matrix Biol. 2018 Oct;71-72:51-69. (PMID: 29803938) ACS Appl Mater Interfaces. 2015 Mar 4;7(8):4833-43. (PMID: 25658033) Bioconjug Chem. 2005 May-Jun;16(3):729-34. (PMID: 15898744) Tissue Eng Part B Rev. 2016 Jun;22(3):193-207. (PMID: 26671674) Elife. 2019 Jan 11;8:. (PMID: 30632962) Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18587-91. (PMID: 19843692) Bioorg Chem. 2007 Jun;35(3):205-20. (PMID: 17223161) PLoS One. 2016 Jun 09;11(6):e0156783. (PMID: 27280771) Proc Nutr Soc. 2001 May;60(2):275-81. (PMID: 11681643) J Vis Exp. 2018 Jul 18;(137):. (PMID: 30080207) Biomater Sci. 2020 Aug 7;8(15):4334-4345. (PMID: 32608413) Bioconjug Chem. 2007 Nov-Dec;18(6):1847-54. (PMID: 17922547) Biomaterials. 2008 May;29(15):2370-7. (PMID: 18295878) Biomacromolecules. 2013 Sep 9;14(9):3047-54. (PMID: 23844746) Clin Oral Implants Res. 2011 Nov;22(11):1247-54. (PMID: 21518006) JCI Insight. 2019 Sep 19;4(18):. (PMID: 31534047) Adv Healthc Mater. 2017 Dec;6(23):. (PMID: 29171714) Tissue Eng. 2007 May;13(5):1025-34. (PMID: 17417949) Arthritis Rheum. 1994 Apr;37(4):537-44. (PMID: 8147931) Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Nov;11(6):e1576. (PMID: 31329375) Biochem Biophys Res Commun. 1991 May 31;177(1):74-82. (PMID: 1710455) Nano Lett. 2015 Nov 11;15(11):7755-65. (PMID: 26503136) Biomaterials. 2005 Oct;26(30):5991-8. (PMID: 15878198) Int J Mol Med. 2008 Mar;21(3):271-9. (PMID: 18288373) Biomaterials. 1999 Dec;20(23-24):2323-31. (PMID: 10614938) J Orthop Res. 2014 Sep;32(9):1161-6. (PMID: 24839051) Tissue Eng Part A. 2018 Jul;24(13-14):1112-1124. (PMID: 29343182) J Bone Miner Res. 2001 Feb;16(2):277-88. (PMID: 11204428) Biomed Mater. 2015 Jun 24;10(3):035016. (PMID: 26107534) J Biomed Mater Res A. 2004 Mar 1;68(3):458-72. (PMID: 14762925) J Mater Chem B. 2018 Jun 7;6(21):3497-3514. (PMID: 32254445) Nature. 1984 May 3-9;309(5963):30-3. (PMID: 6325925) Biomaterials. 2010 Mar;31(9):2470-6. (PMID: 20022630) Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E794-801. (PMID: 18378961) Nano Lett. 2017 Mar 8;17(3):1685-1695. (PMID: 28233497) Int J Biol Sci. 2020 Jan 14;16(4):644-654. (PMID: 32025212) Oxid Med Cell Longev. 2015;2015:632902. (PMID: 25722795) J Biomed Mater Res A. 2014 Dec;102(12):4526-35. (PMID: 24677783) Bioengineered. 2018 Jan 1;9(1):38-47. (PMID: 29095664) J Biomed Mater Res A. 2005 Nov 1;75(2):249-55. (PMID: 16106438) Int J Mol Sci. 2018 Oct 26;19(11):. (PMID: 30373138) Science. 2009 Apr 3;324(5923):59-63. (PMID: 19342581) J Mater Sci Mater Med. 2017 Sep 5;28(10):156. (PMID: 28875425) J Mater Chem B. 2015 Jul 14;3(26):5197-5209. (PMID: 32262595) Tissue Eng Part A. 2015 Feb;21(3-4):757-66. (PMID: 25266634) J Biomed Mater Res A. 2018 Feb;106(2):419-427. (PMID: 28971567) |
| فهرسة مساهمة: | Keywords: (adhesion peptide) RGD; Arg-Gly-Asp; bone; cartilage; tissue engineering |
| تواريخ الأحداث: | Date Created: 20220103 Latest Revision: 20220104 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC8714999 |
| DOI: | 10.3389/fbioe.2021.773636 |
| PMID: | 34976971 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2296-4185 |
|---|---|
| DOI: | 10.3389/fbioe.2021.773636 |